Adverum Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- Adverum Biotechnologies's estimated annual revenue is currently $42.2M per year.
- Adverum Biotechnologies's estimated revenue per employee is $193,750
- Adverum Biotechnologies's total funding is $648.5M.
Employee Data
- Adverum Biotechnologies has 218 Employees.
- Adverum Biotechnologies grew their employee count by 26% last year.
Adverum Biotechnologies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
3 | Chief Commercial Officer | Reveal Email/Phone |
4 | Chief Commercial Officer | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | VP, Clinical Development and Access Strategy | Reveal Email/Phone |
7 | VP FP&A | Reveal Email/Phone |
8 | Head Medical Writing and Transparency at Adverum | Reveal Email/Phone |
9 | SVP, General Counsel | Reveal Email/Phone |
10 | VP – Business Development | Reveal Email/Phone |
Adverum Biotechnologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Adverum Biotechnologies?
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration. For more information, please visit www.adverum.com.
keywords:N/A
$648.5M
Total Funding
218
Number of Employees
$42.2M
Revenue (est)
26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Adverum Biotechnologies News
REDWOOD CITY, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company...
REDWOOD CITY, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company...
REDWOOD CITY, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company...
Other Companies in Redwood City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $64.7M | 218 | 5% | N/A |
#2 | $74.6M | 219 | 26% | N/A |
#3 | $34.9M | 219 | N/A | N/A |
#4 | $35.4M | 222 | N/A | N/A |
#5 | $34.6M | 223 | N/A | N/A |